The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within ...

Japanese drugmaker Astellas Pharma has won European Commission (EC) approval for Padcev (enfortumab vedotin) in combination ...

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

FORT LAUDERDALE, FL / ACCESS Newswire / June 25, 2026 / Sunshine Biopharma Inc. (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, ...

Terminal-Network-Business Synergy" concluded in Shanghai. Industry leaders from CAICT, GSMA, China Mobile, Huawei, 3GPP, GSMA ...

Pembrolizumab alongside belzutifan reduced the risk of disease recurrence, metastasis, or death by 28% compared with pembrolizumab alone. The approval was supported by data from the randomized, double ...

Investors have poured billions into the hunt for the next Keytruda. The latest data carries a sobering message: there may be no single successor to Merck’s mega-blockbuster in cancer.

Trodelvy is now FDA-approved for first-line treatment of advanced TNBC, significantly improving PFS in phase 3 trials.

Ford is making efforts to keep the Explorer as exciting as possible and is bringing the Sinister Package into the lineup for 2027. This means that the model is getting black wheels, black and red ...

This is an updated version of a story first published on March 22, 2026. The original video can be viewed here. The war in Iran is highlighting the importance of ships – not just warships but cargo ...

The tracking mechanism will be implemented over the next two years — by July 2027 for vaccines, narcotics, and anticancer ...